About this trial
The goal of this observational study is to learn how the timing of mobilisation after endovascular thrombectomy (EVT) affects complications in patients with acute ischaemic stroke. The main questions it aims to answer are:
Does mobilisation approximately 12 hours after EVT, compared to approximately 24 hours after EVT, affect the risk of complications such as access site haematoma (ASH), venous thromboembolism (VTE), infections, and delirium? How common are these complications after EVT, and which factors are associated with increased risk?
Participants undergoing EVT as part of their regular stroke care at two hospitals with different mobilisation routines will be followed during their hospital stay. Researchers will collect information about mobilisation timing, complications, clinical assessments, and medical history using case report forms, electronic health records, and national stroke registries.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Undergone endovascular thrombectomy for acute ischaemic stroke
Minimum 18 years old
Disqualifiers
Residing from outside primary catchment area
Spending more than 24 hrs in ICU post thrombectomy
Trial population
Adult patients with acute ischaemic stroke treated with endovascular thrombectomy.
Trial design
Cohort
Prospective
Treatments tested in this trial
Mobilisation
Other interventionOut of bed mobilisation, such as sitting on the edge of the bed, standing or walking with or without support.
Treatment groups
Trial outcomes
Primary outcomes
Access site haematoma
Bleeding from puncture site
Secondary outcomes
sICH
Symptomatic intracranial haemorrhage
Venous thromboembolism
Blood clots in venous system, such as deep vein thrombosis and/or pulmonary embolism.
Infections
Urinary tract infections, pneumonia and/or sepsis.
Delirium
Acute confusion, identified with Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Karolinska Institutet
Lead sponsor
Tampere University Hospital
Collaborator
Region Stockholm
Collaborator